Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sertraline vs CBT in Depression and Refractory Epilepsy
NCT00026637Phase 3Completed
- Sponsor
- Columbia University
- Start
- Aug 2001
- Primary completion
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sertraline in major depressive disorder (MDD), sponsored by Columbia University. Started Aug 2001; status: completed.
02
Drugs
sertraline
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00026637.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00026637.